Immunai
Immunai is an AI-powered biotechnology platform that combines machine learning, single-cell genomics, and immunology to accelerate drug discovery, optimize clinical trials, and improve immune-based therapies for pharmaceutical research.
What is Immunai AI?
Immunai is an AI-powered research platform that uses artificial intelligence, machine learning, and single-cell multiomics to sort of decode the human immune system. In general, the company helps pharmaceutical organizations locate therapeutic targets, get cleaner clinical trial outcomes, and speed up the creation of immune-based medicines. Their own immune database, plus the computational platform, turns messy complex biological data into something actionable, so people can move faster with precision medicine and drug discovery. By combining computational biology with advanced immunology, Immunai helps researchers understand how diseases work, predict how patients will respond to treatments, and lower risks during drug development. The end result is biomedical research that feels more efficient, more scalable, and also clearly more data-driven.
Founded in 2018, Immunai has raised well over 295 million dollars in funding and employs over 110 professionals, including more than 80 PhDs. The company operates across New York, Tel Aviv, Prague, and Zurich while collaborating with more than 27 pharmaceutical and research organizations. Its proprietary AMICA immune atlas is among the world's largest immune-focused single-cell datasets, enabling AI-powered drug discovery, target identification, and clinical trial optimization for leading global biopharmaceutical companies.
- Founder Name: Noam Solomon
- Launch Date: December 2018
Use Cases
- Drug target discovery
- Clinical trial optimization
- Precision medicine research
- Biomarker discovery
- Immunotherapy development
- Cancer research
- Autoimmune disease research
- Pharmaceutical research and development
- Immune system mapping
- Drug candidate evaluation
Technology
- Artificial Intelligence
- Machine Learning
- Single-cell Genomics
- Multiomics Analysis
- Computational Biology
- Bioinformatics
- Functional Genomics
- Predictive Analytics
- Immune Cell Profiling
- Cloud-based Data Platform
Key Features
Immunai AI's key features are
- AI-Powered Drug Discovery: Uses advanced artificial intelligence to identify promising drug targets and accelerate therapeutic research.
- AMICA Immune Atlas: Features one of the world's largest single-cell immune databases for comprehensive immune system analysis.
- Single-Cell Multiomics Analysis: Integrates genomics, transcriptomics, and proteomics data to provide deeper biological insights.
- Target Identification: Helps researchers discover and validate novel therapeutic targets for immune-related diseases.
- Biomarker Discovery: Identifies predictive biomarkers to support personalized medicine and improve patient outcomes.
- Clinical Trial Optimization: Uses AI-driven immune profiling to improve patient selection, trial design, and treatment response prediction.
- Machine Learning Models: Delivers predictive analytics for disease progression, drug efficacy, and immune responses.
- Functional Genomics Platform: Validates AI-generated discoveries using experimental biological data.
- Pharmaceutical Collaboration Platform: Enables secure collaboration between biotech companies and pharmaceutical research teams.
- Precision Medicine Support: Provides actionable immune insights for developing personalized therapies.
Pricing
- Custom enterprise pricing
- Quote-based pricing
- Strategic pharmaceutical partnerships
- Research collaboration pricing
- No publicly available subscription plans
- Contact the Immunai sales team for customized pricing
Disclaimer: For the latest and most accurate pricing information, please visit the official Immunai AI website.
Who is using it?
A diverse range of users and organizations utilize Immunai AI
- Pharmaceutical companies
- Biotechnology companies
- Drug discovery teams
- Clinical research organizations
- Immunology researchers
- Academic research institutions
- Precision medicine organizations
- Healthcare innovation companies
Alternatives
Some Immunai AI alternatives are
- Insitro
- Recursion Pharmaceuticals
- BenevolentAI
- Exscientia
- Owkin
- Tempus AI
- Schrödinger
- Atomwise
- Verge Genomics
- Relay Therapeutics
Immunai Comparison with Competitors
| Tool Name | Primary Focus | AI Technology | Best For | Pricing Model |
|---|---|---|---|---|
| Immunai | Immune system drug discovery | Machine learning and multiomics | Immunology and precision medicine | Custom enterprise |
| Insitro | Drug discovery | Machine learning | Pharmaceutical research | Enterprise |
| Exscientia | AI drug design | Artificial intelligence | Drug candidate discovery | Enterprise |
| BenevolentAI | Biomedical research | Knowledge graph AI | Drug target identification | Enterprise |
| Owkin | Federated AI | Machine learning | Clinical research | Enterprise |
How Did We Rate Immunai?
- Creative Accuracy: 9.5/10
- User Experience: 8.8/10
- Tools & Capabilities: 9.7/10
- Speed & Efficiency: 9.3/10
- Creative Freedom: 8.7/10
- Trust & Transparency: 9.4/10
- Help & Community: 8.5/10
- Value for Money: 8.9/10
- Ecosystem Fit: 9.6/10
- Overall Score: 9.2/10
Conclusion
Immunai has established itself as one of the leading AI-driven biotechnology platforms, focused on decoding the immune system for the next generation of drug discovery. It leans hard on artificial intelligence along with machine learning, single-cell genomics, and a wide set of immune datasets so pharmaceutical companies can make smarter decisions all through the research and development cycle. The platform helps find new targets, identify biomarkers, and improve clinical trials, while also reducing development risks and increasing the chances of successful treatments. Even though the pricing is enterprise-oriented and not publicly disclosed (so yeah, you won’t see it listed), Immunai still brings noticeable value to large biomedical organizations that want innovative AI solutions for precision medicine, immunology, and advanced pharmaceutical research.
People are also reading
FAQ
What is Immunai?
Immunai is an AI-powered biotechnology platform that helps pharmaceutical companies accelerate drug discovery and precision medicine using immune system data.
Is Immunai free to use?
No. Immunai provides custom enterprise solutions with pricing available upon request.
Which industries use Immunai?
Biotechnology, pharmaceuticals, healthcare research, immunology, and precision medicine.
What technologies power Immunai?
Artificial intelligence, machine learning, single-cell genomics, multiomics, bioinformatics, and computational biology.
What makes Immunai unique?
Its AMICA immune atlas, AI-powered analytics, and deep expertise in immune system biology enable advanced drug discovery and clinical trial optimization.
User Reviews
No reviews yet for Immunai.
Featured Tools
Featured AI tools from TechShark
Kimi AI
Kimi AI is an advanced AI assistant developed by Moonshot AI that helps you chat, research, write, code, and automate tasks in one place. It supports web search, file analysis, and multimodal inputs, and can even run autonomous “agent” workflows to complete complex tasks end-to-end.
Freemium
Fashion Diffusion AI
Fashion Diffusion is an AI-powered fashion design platform that helps brands and designers create clothing designs, virtual try-ons, AI models, product photos, and marketing visuals faster and cost-effectively.
Paid
Veo 4
Veo 4 AI is an AI video creation platform that generates dramatic videos from text, images, audio, and video prompts using realistic motion and synchronized sound.
Paid
Happy Horse
HappyHorse AI is an AI-powered video generator that creates cinematic videos with synchronized audio from text, images, and prompts instantly.
Paid
Alternatives
Alternatives to Immunai
Immunai AI alternatives include Verisl, Cytora, Shift Technology, Socotra, Earnix, and Guidewire. Immunai is an AI-powered biotech company that uses artificial intelligence, multiomics, and single-cell immune data to help pharmaceutical companies discover drug targets, optimize clinical trials, and develop precision therapies. Its advanced immune intelligence platform enables faster, data-driven decisions throughout the drug development lifecycle.
4.8Getwoord
Text-to-Speech
GetWoord is an AI-powered text-to-speech platform that converts written text into natural-sounding audio using realistic voices. It supports 100+ voices across multiple languages, lets you customize tone and speed, and export audio for uses like podcasts, e-learning, and content creation.
4.9Minicod
Research
Minicod is an academic data aggregation API, research intelligence platform, and Model Context Protocol (MCP) server that unifies scholarly literature queries across Semantic Scholar, OpenAlex, and PubMed into a single normalized JSON schema, complete with citation graph traversal, open-access link discovery, and an OpenAI-compatible endpoint.
4.9Gemma 4
Research
Gemma 4 is a family of open AI models from Google DeepMind designed for advanced reasoning, coding, and agent workflows. It supports multimodal inputs like text, images, and audio, runs efficiently on devices from phones to laptops, and offers high performance with open weights for customization.
DeepSearch Bio
Research
DeepSearch is an AI research assistant that helps you explore complex topics, analyze information, and generate detailed insights quickly. It combines web data, documents, and reasoning to produce structured answers, summaries, and reports—making it useful for research, learning, and decision-making tasks.
4.6The AI Scientist
Research
The AI Scientist is an autonomous research system developed by Sakana AI that performs the complete scientific research workflow with minimal human involvement. It generates research ideas, reviews existing literature, writes code, runs experiments, analyzes findings, creates visualizations, and produces research papers, helping researchers accelerate innovation and scientific discovery.
4.8Articos
Research
Articos is an AI-powered user research platform that runs full interview-based studies using synthetic personas and delivers structured insights in about 30 minutes—without recruiting real users. It helps teams validate ideas, messaging, and UX quickly at a fraction of traditional research cost.
4.8OpenAI Prism
Research
Prism is a scientific writing workspace developed by OpenAI that combines LaTeX editing, AI-assisted writing, literature support, and real-time collaboration in one cloud-based environment. It helps researchers draft, revise, format, and organize research papers faster while reducing manual editing, version conflicts, and document management tasks.
4.8Mobile ALOHA
Research
Mobile ALOHA is an open research system for teaching robots whole-body mobile manipulation through human demonstrations. It combines two robotic arms, a mobile base, cameras, teleoperation hardware, and imitation learning. Researchers can collect demonstrations, train models, and evaluate robots on challenging household and mobile manipulation tasks.
4.7Cohere Parse
Research
Cohere Parse is an enterprise vision-language document parsing API that transforms unstructured PDFs, financial statements, slides, and images into clean, structured Markdown, HTML tables, and coordinate-grounded content blocks at high throughput and ultra-low cost.